Cargando…

Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy

Cyclin-dependent kinase 2 (CDK2) is an essential protein kinase involved in the cell cycle regulation. The abnormal activity of CDK2 is associated with cancer progression and metastasis. Here, we have performed structure-based virtual screening of the PubChem database to identify potent CDK2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammad, Taj, Batra, Sagar, Dahiya, Rashmi, Baig, Mohammad Hassan, Rather, Irfan Ahmad, Dong, Jae-June, Hassan, Imtaiyaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943647/ https://www.ncbi.nlm.nih.gov/pubmed/31847444 http://dx.doi.org/10.3390/molecules24244589

Ejemplares similares

Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy
por: Gupta, Preeti, et al.
Publicado: (2019)

Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing
por: Baig, Mohammad Hassan, et al.
Publicado: (2022)

Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3
por: Dahiya, Rashmi, et al.
Publicado: (2019)

Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics
por: Yousuf, Mohd, et al.
Publicado: (2022)

Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
por: Roy, Sonam, et al.
Publicado: (2020)

Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies
por: Mohammad, Taj, et al.
Publicado: (2020)

Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach
por: Shafie, Alaa, et al.
Publicado: (2021)

Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy
por: Mohammad, Taj, et al.
Publicado: (2020)

Insights into the Conserved Regulatory Mechanisms of Human and Yeast Aging
por: Dahiya, Rashmi, et al.
Publicado: (2020)

Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
por: Sharma, Tanuj, et al.
Publicado: (2021)

Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors
por: Khan, Nashrah Sharif, et al.
Publicado: (2020)

Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
por: Shamsi, Anas, et al.
Publicado: (2020)

Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study
por: Baig, Mohammad Hassan, et al.
Publicado: (2021)

Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
por: Shafie, Alaa, et al.
Publicado: (2021)

Effect of pH on the structure and function of cyclin-dependent kinase 6
por: Yousuf, Mohd, et al.
Publicado: (2022)

Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies
por: Khan, Parvez, et al.
Publicado: (2017)

Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
por: Roy, Sonam, et al.
Publicado: (2020)

Fragment screening of cyclin G-associated kinase by weak affinity chromatography
por: Meiby, Elinor, et al.
Publicado: (2012)

Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones
por: Voura, Maria, et al.
Publicado: (2019)

Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
por: Jairajpuri, Deeba Shamim, et al.
Publicado: (2020)

Clinical anticancer drug development: targeting the cyclin-dependent kinases
por: Benson, C, et al.
Publicado: (2005)

Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
por: Shamsi, Anas, et al.
Publicado: (2019)

Identification and Evaluation of Inhibitors of Lipase from Malassezia restricta using Virtual High-Throughput Screening and Molecular Dynamics Studies
por: Ali, Shahid, et al.
Publicado: (2019)

Biophysical Insights into Implications of PEG-400 on the α-Crystallin Structure: Multispectroscopic and Microscopic Approach
por: Shamsi, Anas, et al.
Publicado: (2020)

Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6
por: Yousuf, Mohd, et al.
Publicado: (2020)

Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
por: Anwar, Saleha, et al.
Publicado: (2020)

Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics
por: Anjum, Farah, et al.
Publicado: (2022)

Iron response elements (IREs)-mRNA of Alzheimer's amyloid precursor protein binding to iron regulatory protein (IRP1): a combined molecular docking and spectroscopic approach
por: Khan, Mateen A., et al.
Publicado: (2023)

Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
por: Sallam, Hatem, et al.
Publicado: (2013)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
por: Yang, Chunmin, et al.
Publicado: (2022)

A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma
por: Ahmed, Sarfraz, et al.
Publicado: (2022)

Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey
por: Mariaule, Gaëlle, et al.
Publicado: (2014)

MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer’s Disease
por: Waseem, Rashid, et al.
Publicado: (2021)

B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy
por: Alam, Manzar, et al.
Publicado: (2021)

Evaluation of Binding of Rosmarinic Acid with Human Transferrin and Its Impact on the Protein Structure: Targeting Polyphenolic Acid-Induced Protection of Neurodegenerative Disorders
por: Shamsi, Anas, et al.
Publicado: (2020)

Multispectroscopic and Molecular Docking Insight into Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational Therapy Approach to Fight Alzheimer’s Disease
por: Waseem, Rashid, et al.
Publicado: (2021)

FNDC5/Irisin: Physiology and Pathophysiology
por: Waseem, Rashid, et al.
Publicado: (2022)

Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4
por: Warenius, Hilmar M, et al.
Publicado: (2011)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8oir7hp9far7i2c23fc28atur6